Study: Insulin payment strategy could reduce costs for insurers, patients
![insulin-study](/sites/default/files/styles/900x400/public/2019-02/insulin-study.jpg?itok=_M6ww_II)
A new study adds to a growing body of literature suggesting that human insulins may result in similar clinical outcomes as higher cost insulin analogues for many patients with type 2 diabetes, according to a report last week in JAMA. The study looked at an initiative implemented by a Medicare Advantage plan to encourage members with diabetes to switch from insulin analogue to human insulin. The program was associated with a small increase in population-level HbA1C, but no significant change in rates of serious hypoglycemia or hyperglycemia. Human insulin use increased to 70 percent of insulin prescriptions over the three-year initiative, while overall expenditures for insulin decreased by more than 50 percent.
Related News Articles
Headline
Two clinicians and a vehicle — that's the model Sheppard Pratt has been using to give behavioral health access to its communities. In this conversation, Jason…
Headline
Boston Medical Center is the winner of the AHA’s 2024 Foster G. McGaw Prize, which recognizes the efforts of hospitals and health systems to improve the health…
Chairperson's File
The connection between a hospital and its community is special. Hospitals are woven into the fabric of their communities, and working together, hospitals and…
Headline
The AHA’s Hospital Community Collaborative has launched the HCC Academy, with specialized workshops for leaders from hospitals, health systems and community…
Headline
The AHA Aug. 6 released the first poster of the People Matter, Words Matter series to be translated into Spanish. Las Personas Importan, Las Palabras Importan…
Headline
Mary Thompson — a member of AHA’s Committee on Behavioral Health and president of Trillium Place, a mental health and addiction recovery organization…